passage bio stock forecast

6 equities research analysts have issued 1-year target prices for Passage Bios shares. Summary of all time highs changes and price drops for Passage Bio.

Time To Go Bottom Fishing These 3 Strong Buy Stocks Are On Sale Nasdaq

Has a 52-week low of 186 and a 52-week high of 1789.

. Buy or sell Fortress Biotech stock. 1 day agoPassage Bio stock opened at 203 on Friday. That PASSAGE BIOs share price could reach 1833 by Mar 8 2023.

If you are looking for stocks with good return Passage Bio Inc stock can be a bad high-risk 1-year investment option. PHILADELPHIA March 15 2022 GLOBE NEWSWIRE -- Passage Bio Inc. On average they anticipate Passage Bios stock price to reach 2000 in the next year.

NASDAQPASG price on Wednesday May 04 rose 1378 above its previous days close as an upside momentum from buyers pushed the stocks. Given that these returns are generally. Youll find the Fortress.

Wall Street Stock Market Finance report prediction for the future. Find the latest Passage Bio Inc. See Passage Bio Inc.

Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of. Fortress Biotech Inc Stock Market info Recommendations. Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business.

Passage Bio Incs market cap currently stands at around 16811 million with investors looking forward to this quarters earnings report slated for Mar 01 2022 Mar 07. PASG stock quote history news and other vital information to help you with your stock trading and investing. The stock was bought at an.

What analysts cover Passage Bio. In total the offering brought in 216 million for the. Estimated cash runway extended into Q2 2024.

On average Wall Street analysts predict. The average price target is 2000 with a high forecast of 3400 and a low forecast. Passage Bio NASDAQPASG intends to raise 125 million in an IPO.

In other news major shareholder Orbimed Advisors Llc acquired 369100 shares of Passage Bio stock in a transaction on Thursday January 20th. Jan 6 2022 219AM EST. Shares of Passage Bio were trading at 338 as of March 01.

This biotech has a lead gene. Passage Bio Inc real time quote is equal to. This suggests a possible upside of 9526 from.

Passage Bio Inc PASG shares closed 36 lower than its previous 52 week low giving the company a market cap of 333M. Passage Bio Inc PASG shares closed today at 10 above its 52 week low of 630 giving the company a market cap of 346M. Their forecasts range from 600 to 3400.

PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Based on 5 Wall Street analysts offering 12 month price targets for Passage Bio in the last 3 months. Please note that any opinions estimates or.

Is followed by the analysts listed above. This is according to an S-1 registration statement filed with the SEC. Passage Bio NASDAQPASG intends to raise 126 million in an IPO of its common stock per an amended registration statement.

Over the last 52-week period shares are down 8296. PASG a clinical-stage genetic medicines. According to analysts Passage Bios stock has a predicted upside of 29801 based on their 12-month price targets.

The average PASSAGE BIO stock price prediction forecasts a potential upside of 49139 from the current PASG share price of 310. Analysts forecast that Passage Bio Inc. Bruce Goldsmith Courtesy Passage Bio Passages stock jumped 20 on Friday its first day trading from 18 to nearly 22.

Dec 30 2021 403AM EST.

Passage Bio Inc Investors And News Stock Information